• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚急性甲状腺炎患者的特征。

Characteristics of patients with subacute thyroiditis.

机构信息

Department of Clinical Biochemistry, Aalborg University Hospital.

Department of Clinical Medicine, Aalborg University.

出版信息

Dan Med J. 2023 Oct 24;70(11):A05230318.

PMID:37897374
Abstract

INTRODUCTION

The diagnosis and management of subacute thyroiditis (SAT) may be challenging, and more evidence on patient and disease characteristics is warranted.

METHODS

This was a retrospective cohort study of all patients in the North Denmark Region with a SAT diagnosis in the Danish National Patient Registry, 2016-2018. The medical records and biochemical results prior to the diagnosis and during a two-year follow-up period were reviewed.

RESULTS

A total of 71 patients with a SAT diagnosis were identified, and the diagnosis was verified in 44 (62.0%) cases with an incidence rate of 2.4/100,000/year. Patients with verified SAT were predominantly females (72.7%) with a median age of 50.7 years. Biochemical results showed thyrotoxicosis at the initial examination in 69.8% and elevated C-reactive protein in 86.5% of patients. Longitudinal biochemical assessment showed a biphasic response (median thyroid-stimulating hormone, initially: 0.02 mIU/l, at three months: 4.7 mIU/l and 2.4 mIU/l after two years). Treatment with non-steroidal anti-inflammatory drugs, beta-blockers and/or prednisolone was initiated in 23 of the 38 patients (60.5%) evaluated, and ten of 33 patients (30.3%) with follow-up data received thyroid hormone replacement therapy.

CONCLUSION

In the North Denmark Region, a hospital diagnosis of SAT was verified in less than two thirds of cases. Further large studies are warranted to extend the findings concerning the treatment and outcome of SAT.

FUNDING

None.

TRIAL REGISTRATION

Not relevant.

摘要

简介

亚急性甲状腺炎(SAT)的诊断和管理可能具有挑战性,需要更多关于患者和疾病特征的证据。

方法

这是一项回顾性队列研究,纳入了 2016 年至 2018 年期间丹麦全国患者注册中心中所有被诊断为 SAT 的北丹麦地区患者。对诊断前和两年随访期间的病历和生化结果进行了回顾。

结果

共确定了 71 例 SAT 诊断患者,其中 44 例(62.0%)经证实,发病率为 2.4/100,000/年。经证实的 SAT 患者主要为女性(72.7%),中位年龄为 50.7 岁。生化结果显示,69.8%的患者初诊时表现为甲状腺毒症,86.5%的患者 C 反应蛋白升高。纵向生化评估显示出双相反应(中位数促甲状腺激素,初诊时:0.02 mIU/l,三个月时:4.7 mIU/l,两年后为 2.4 mIU/l)。对 38 例评估患者中的 23 例(60.5%)启动了非甾体抗炎药、β 受体阻滞剂和/或泼尼松龙治疗,33 例有随访数据的患者中有 10 例(30.3%)接受了甲状腺激素替代治疗。

结论

在北丹麦地区,不到三分之二的 SAT 病例被医院确诊。需要进一步开展大型研究,以扩展关于 SAT 治疗和结局的发现。

资金

无。

试验注册

不相关。

相似文献

1
Characteristics of patients with subacute thyroiditis.亚急性甲状腺炎患者的特征。
Dan Med J. 2023 Oct 24;70(11):A05230318.
2
Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients-a systematic review and meta-analysis.亚急性甲状腺炎患者中糖皮质激素与非甾体抗炎药治疗效果的比较:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Apr 23;15:1384365. doi: 10.3389/fendo.2024.1384365. eCollection 2024.
3
Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone.对36例接受泼尼松龙治疗的亚急性甲状腺炎患者复发情况的评估。
Intern Med. 2001 Apr;40(4):292-5. doi: 10.2169/internalmedicine.40.292.
4
An Evaluation of the Results of the Steroid and Non-steroidal Anti-inflammatory Drug Treatments in Subacute Thyroiditis in relation to Persistent Hypothyroidism and Recurrence.亚急性甲状腺炎中甾体和非甾体抗炎药物治疗结果与持续性甲状腺功能减退和复发的关系评估。
Sci Rep. 2019 Nov 15;9(1):16899. doi: 10.1038/s41598-019-53475-w.
5
Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis.泼尼松龙与非甾体抗炎药对亚急性甲状腺炎患者的治疗效果比较。
Endocrine. 2017 Jan;55(1):209-214. doi: 10.1007/s12020-016-1122-3. Epub 2016 Sep 29.
6
Long-term Outcome of Subacute Thyroiditis.亚急性甲状腺炎的长期转归。
Exp Clin Endocrinol Diabetes. 2020 Nov;128(11):703-708. doi: 10.1055/a-0998-8035. Epub 2019 Sep 23.
7
HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.接种 SARS-CoV-2 疫苗后发生亚急性甲状腺炎和格雷夫斯病的患者的 HLA 分型:病例报告。
BMC Endocr Disord. 2023 Mar 7;23(1):54. doi: 10.1186/s12902-023-01287-5.
8
Initial treatment with 15 mg of prednisolone daily is sufficient for most patients with subacute thyroiditis in Japan.在日本,大多数亚急性甲状腺炎患者每日接受 15 毫克泼尼松龙的初始治疗就足够了。
Thyroid. 2013 Mar;23(3):269-72. doi: 10.1089/thy.2012.0459.
9
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review.COVID-19 继发亚急性甲状腺炎的危险因素、治疗方法和结局:系统评价。
Intern Med J. 2022 Apr;52(4):522-529. doi: 10.1111/imj.15432.
10
Two-Years Prospective Follow-Up Study of Subacute Thyroiditis.亚急性甲状腺炎的两年前瞻性随访研究。
Front Endocrinol (Lausanne). 2020 Feb 28;11:47. doi: 10.3389/fendo.2020.00047. eCollection 2020.

引用本文的文献

1
Differential diagnosis of Hashimoto's thyroiditis: The importance of pathological anatomy.桥本甲状腺炎的鉴别诊断:病理解剖学的重要性。
J Biol Methods. 2025 Aug 7;12(3):e99010064. doi: 10.14440/jbm.2024.0139. eCollection 2025.
2
Case Report: SARS-CoV-2-associated immune dysfunction manifesting as concurrent fulminant type 1 diabetes mellitus and subacute thyroiditis.病例报告:SARS-CoV-2相关免疫功能障碍表现为暴发性1型糖尿病和亚急性甲状腺炎并发。
Front Med (Lausanne). 2025 Aug 18;12:1644656. doi: 10.3389/fmed.2025.1644656. eCollection 2025.
3
Unilateral pharyngalgia as the dominant symptom in subacute thyroiditis: Case series and analysis of diagnostic pitfalls in clinical practice.
以单侧咽痛为主要症状的亚急性甲状腺炎:病例系列及临床实践中诊断陷阱分析
J Int Med Res. 2025 Aug;53(8):3000605251370311. doi: 10.1177/03000605251370311. Epub 2025 Aug 28.
4
Subacute thyroiditis in pregnancy: a narrative review.妊娠期亚急性甲状腺炎:一篇叙述性综述
Thyroid Res. 2025 Feb 17;18(1):4. doi: 10.1186/s13044-024-00221-8.
5
Incidence of Graves' Disease with Validation and Completeness of the Diagnosis for Registry Extracts in the Danish National Patient Register.丹麦国家患者登记处中格雷夫斯病的发病率及登记提取物诊断的验证与完整性
Clin Epidemiol. 2024 Oct 9;16:699-705. doi: 10.2147/CLEP.S484335. eCollection 2024.
6
Diagnoses of obstetric and postpartum thyroid disease: a Danish validation study.产科和产后甲状腺疾病的诊断:一项丹麦验证研究。
Sci Rep. 2024 Apr 16;14(1):8777. doi: 10.1038/s41598-024-59636-w.